XML 118 R103.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings per share - Summary of earnings per share (Detail) - AUD ($)
12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Earnings per share [abstract]      
Loss after income tax attributable to the owners of Kazia Therapeutics Limited $ (8,421,960) $ (12,467,466) $ (10,270,000)
Loss after income tax attributable to the owners of Kazia Therapeutics Limited $ (8,422,000) $ (12,467,000) $ (10,270,000)
Weighted average number of ordinary shares used in calculating basic earnings per share 117,674,543 73,053,514 57,503,555
Weighted average number of ordinary shares used in calculating diluted earnings per share 117,674,543 73,053,514 57,503,555
Basic earnings per share $ (7.16) $ (17.07) $ (17.86)
Diluted earnings per share $ (7.16) $ (17.07) $ (17.86)